<p>BALB/c mice were sensitized with 0.05% OVA and 2% aluminum hydroxide (Alum) solution by intraperitoneal injection on days 1, 8, and 15. Mice were challenged with a 4% OVA solution by daily intranasal instillation from day 22 to day 29. With sensitization and challenge, 2ME2, CoCl<sub>2</sub> or vehicle (DMSO) solution was given by intraperitoneal injection 2 hours before each intranasal challenge. SAL, saline; VEH, vehicle; IP, intraperitoneal injection; IN, intranasal instillation.</p
<p>(<b>a</b>) Mice were sensitized i.p. with 10 µg OVA adsorbed to 1.5 mg Al(OH)<sub>3</sub> or with...
<p>(A) Mice were sensitized on days 0, 1, 7, and 8 by intraperitoneal injection of ovalbumin (OVA) a...
<p>Adult female BALB/c mice were infected with influenza A or media only 21 days before they were se...
<p>Mice in the AR, positive, and negative groups were sensitized with 100 μg of ovalbumin (OVA) and ...
<p>Mice were sensitised to OVA by three intraperitoneal (i.p.) injections on days 0, 14 and 21 with ...
<p>Mice were sensitized by i.p. administration of 2 µg ovalbumin admixed with 100 µl alum at day 0 a...
<p>BALB/c mice (11–13 per group) were sensitized by intranasal administration of 100 µg of ovalbumin...
<p>The OVA-sensitized and challenged group: mice were sensitized on days 1, 3, 5, 7, 9, 11 and 13 by...
<p>Schematic representation of the timing of sensitization by intraperitoneal injection of OVA-Alum;...
<p>Mice were intraperitonealy sensitized with OVA/Alum with either hi-dose OVA (1000 µg) or low-dose...
<p>Mice were sensitized with OVA (100 μg) or saline applied at 100 μl to a sterile patch. The patch ...
<p>At 7 days after the last allergen sensitization, mice were challenged by allergen, followed by co...
<p>For sensitization, BALB/c mice received an i.p injection of OVA or PBS with aluminum hydroxide on...
<p>Mice received 2 rounds of intranasal delivery of E-selectin or PBS. The 2 rounds of intranasal de...
<p>On days 0–4 and 7–11, BALB/c mice were daily received PBS, recombinant or wild-type <i>L. lactis<...
<p>(<b>a</b>) Mice were sensitized i.p. with 10 µg OVA adsorbed to 1.5 mg Al(OH)<sub>3</sub> or with...
<p>(A) Mice were sensitized on days 0, 1, 7, and 8 by intraperitoneal injection of ovalbumin (OVA) a...
<p>Adult female BALB/c mice were infected with influenza A or media only 21 days before they were se...
<p>Mice in the AR, positive, and negative groups were sensitized with 100 μg of ovalbumin (OVA) and ...
<p>Mice were sensitised to OVA by three intraperitoneal (i.p.) injections on days 0, 14 and 21 with ...
<p>Mice were sensitized by i.p. administration of 2 µg ovalbumin admixed with 100 µl alum at day 0 a...
<p>BALB/c mice (11–13 per group) were sensitized by intranasal administration of 100 µg of ovalbumin...
<p>The OVA-sensitized and challenged group: mice were sensitized on days 1, 3, 5, 7, 9, 11 and 13 by...
<p>Schematic representation of the timing of sensitization by intraperitoneal injection of OVA-Alum;...
<p>Mice were intraperitonealy sensitized with OVA/Alum with either hi-dose OVA (1000 µg) or low-dose...
<p>Mice were sensitized with OVA (100 μg) or saline applied at 100 μl to a sterile patch. The patch ...
<p>At 7 days after the last allergen sensitization, mice were challenged by allergen, followed by co...
<p>For sensitization, BALB/c mice received an i.p injection of OVA or PBS with aluminum hydroxide on...
<p>Mice received 2 rounds of intranasal delivery of E-selectin or PBS. The 2 rounds of intranasal de...
<p>On days 0–4 and 7–11, BALB/c mice were daily received PBS, recombinant or wild-type <i>L. lactis<...
<p>(<b>a</b>) Mice were sensitized i.p. with 10 µg OVA adsorbed to 1.5 mg Al(OH)<sub>3</sub> or with...
<p>(A) Mice were sensitized on days 0, 1, 7, and 8 by intraperitoneal injection of ovalbumin (OVA) a...
<p>Adult female BALB/c mice were infected with influenza A or media only 21 days before they were se...